Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer: A Phase II Study
American Journal of Clinical Oncology, 02/11/2011
Clinical Article
Safran H et al. – Lapatinib is not effective in pancreatic cancer. Evaluation of HER2 inhibitors in pancreatic cancer is not warranted.



